Inferior ST-elevation myocardial infarction managed with a pharmacoinvasive strategy and conservative management of delayed atrioventricular block: classical case report.
Thadathilankal-Jess JohnCharles KyriakakisDon ZachariahAnton DoubellPublished in: European heart journal. Case reports (2020)
We highlight some of the important management principles from the ESC guideline of STEMI including timing and the management of AV block in these patients. In addition, we highlight the role of a pharmacoinvasive strategy for reperfusion where timeous primary percutaneous coronary intervention cannot be performed. The usefulness of such a strategy within the COVID-19 era is also emphasized.
Keyphrases
- st elevation myocardial infarction
- percutaneous coronary intervention
- acute myocardial infarction
- st segment elevation myocardial infarction
- end stage renal disease
- acute coronary syndrome
- case report
- coronary artery disease
- antiplatelet therapy
- coronavirus disease
- ejection fraction
- sars cov
- chronic kidney disease
- newly diagnosed
- coronary artery bypass grafting
- peritoneal dialysis
- atrial fibrillation
- prognostic factors
- heart failure
- blood brain barrier
- patient reported outcomes
- catheter ablation